Folate supplementation reduces the side effects of methotrexate therapy for psoriasis.

about

The Australasian Psoriasis Collaboration view on methotrexate for psoriasis in the Australasian setting.Exploiting the 2-Amino-1,3,4-thiadiazole Scaffold To Inhibit Trypanosoma brucei Pteridine Reductase in Support of Early-Stage Drug Discovery.

P2860

Q38893359-94A8B78D-BC12-407D-BA5D-0879534B144C Q42163449-5FD0DD54-45F0-4A5E-A1BF-C9689A27EBAA

P2860

Folate supplementation reduces the side effects of methotrexate therapy for psoriasis.

Item

http://www.wikidata.org/entity/Q38223934

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Folate supplementation reduces the side effects of methotrexate therapy for psoriasis.

@en

type

Item

label

Folate supplementation reduces the side effects of methotrexate therapy for psoriasis.

@en

prefLabel

Folate supplementation reduces the side effects of methotrexate therapy for psoriasis.

@en

P1476

Folate supplementation reduces the side effects of methotrexate therapy for psoriasis

@en

P2093

Aleksandra Batycka-Baran

http://www.w3.org/2001/XMLSchema#string

Andrzej Bieniek

http://www.w3.org/2001/XMLSchema#string

Wojciech Baran

http://www.w3.org/2001/XMLSchema#string

P2860

The extremely slow and variable activity of dihydrofolate reductase in human liver and its implications for high folic acid intake

The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation.

Systemic methotrexate therapy for psoriasis: past, present and future.

Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial.

Pharmacokinetics and pharmacodynamics of methotrexate in non-neoplastic diseases.

Methotrexate and psoriasis in the era of new biologic agents.

Methotrexate pharmacogenetics: the first step toward individualized therapy in rheumatoid arthritis.

Folate and colorectal cancer: an evidence-based critical review.

Effect of folic or folinic acid supplementation on methotrexate-associated safety and efficacy in inflammatory disease: a systematic review.

Methotrexate and psoriasis: 2009 National Psoriasis Foundation Consensus Conference.

P304

1015-1021

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14740338.2014.933805

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

J Szepietowski

Magdalena Zychowska

P577

2014-06-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263514785

http://www.w3.org/2001/XMLSchema#string

P698

24972718

http://www.w3.org/2001/XMLSchema#string

Folate supplementation reduces the side effects of methotrexate therapy for psoriasis.

about

P2860

P2860

Folate supplementation reduces the side effects of methotrexate therapy for psoriasis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698